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Abstract
Background: Multiplex experimental assays coupled to computational predictions are being increasingly employed
for the simultaneous analysis of many specimens at the genome scale, which quickly generates very large amounts
of data. However, inferring valuable biological information from the comparisons of very large genomic datasets
still represents an enormous challenge.
Results: As a study model, we chose the NFI/CTF family of mammalian transcription factors and we compared the
results obtained from a genome-wide study of its binding sites with chromatin structure assays, gene expression
microarray data, and in silico binding site predictions. We found that NFI/CTF family members preferentially bind
their DNA target sites when they are located around transcription start sites when compared to control datasets
generated from the random subsampling of the complete set of NFI binding sites. NFI proteins preferably associate
with the upstream regions of genes that are highly expressed and that are enriched in active chromatin
modifications such as H3K4me3 and H3K36me3. We postulate that this is a causal association and that NFI proteins
mainly act as activators of transcription. This was documented for one member of the family (NFI-C), which
revealed as a more potent gene activator than repressor in global gene expression analysis. Interestingly, we also
discovered the association of NFI with the tri-methylation of lysine 9 of histone H3, a chromatin marker previously
associated with the protection against silencing of telomeric genes by NFI.
Conclusion: Taken together, we illustrate approaches that can be taken to analyze large genomic data, and
provide evidence that NFI family members may act in conjunction with specific chromatin modifications to
activate gene expression.
Background
High-throughput assays are being widely employed in
various fields of biology. For example in genomics, DNA
microarrays are used to simultaneously measure the
expression levels of nearly all genes of a genome [1,2].
Recently, a new high-throughput method has been
developed for a whole genome mapping of protein-DNA
interactions that is based on the chromatin immunopre-
cipitation and next generation sequencing technology
(method termed chromatin immunoprecipitation
sequencing or ChIP-Seq) [3-8]. These two high-
throughput methods, when combined, are instrumental
to study how transcription factors regulate gene expres-
sion at a global genomic scale. As the costs of new-gen-
eration sequencing and DNA microarrays decrease, such
high-throughput assays should be increasingly used. In
addition, new software tools are emerging rapidly, allow-
ing faster and easier analyses of large-scale genomic
datasets [9-13]. However, extracting the significant and
biologically relevant information from such massive
datasets still represents a great challenge. In purely
experimental studies, the use of negative controls such
as the blank or mock conditions is absolutely necessary.
However, genome-wide computer analyses may lack an
adequate negative control. In such case, a randomly
selected portion of the total dataset can be used as an in
silico negative control, such as for instance a randomly
picked sample of all genomic loci. The size of the
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experimental set, to simplify the statistical analysis
[14,15].
As a study group of proteins, we chose NFI/CTF
family of mammalian transcription factors. NFI/CTF
represents a family of transcription-replication factors
comprising polypeptides encoded by four paralogous
genes located on different chromosomes in mammals
(NFIA, NFIB, NFIC, NFIX) [16,17]. NFI family of pro-
teins displays the unusual property of regulating not
only the initiation of transcription but also of mediat-
ing DNA replication [18]. NFI recognition sequence
were found in the promoter sequences of many cellu-
lar genes [19], where they may act as activator or
repressor of transcription [20-25]. Recently, it has
been proposed that NFI may be involved in a long
range regulation of gene expression, through the for-
mation of chromatin barrier and by blocking the
propagation of a heterochromatic structure [26,27].
NFI binds as a dimer, and its preferred binding
sequence is a palindrome composed of two half sites
TTGGCANNNTGCCAA. A position weight matrix for
the NFI/CTF was established using a collection of over
10,000 SELEX-SAGE selected sites, allowing the pre-
diction of its binding affinity to any genomic sequence
[28]. However, since this prediction matrix is based on
NFI binding specificity in vitro, the specificity of this
family of proteins may be different from that observed
in the cell, where interactions with other transcription
factors may take place and DNA accessibility may be
restrained by chromatin. Here we assessed the in vivo
binding preferences of NFI/CTF, its global functional
properties regarding the regulation of gene expression
and the relationship of NFI binding sites with different
histone methylation markers typical of either an open
or closed chromatin structure.
Results
NFI preferentially binds upstream of transcription
initiation sites in mouse genome
Statistical analysis in genomics often relies on the sub-
sampling of datasets, which requires random sampling
algorithms. We devised a random sampling algorithm
that can be conveniently applied to large genomic data-
sets. The random sampling algorithm C++ source code
is available as a text file online (Additional file 1). Each
randomly generated number is used to extract an entry
line from the main dataset to generate a subset of the
desired size. Simulation experiments indicated that sub-
sampling can be applied to sets of normally distributed
values without loosing the statistical robustness of the
comparisons, provided that relatively large subsets of
data are retained (e.g. equal or greater than 100 indivi-
dual values; see Additional file 2).
W ef i r s tu s e dt h i sr a n d o ms a m p l i n gm e t h o dt oc o m -
pare data from a ChIP-Seq experiment performed on
primary mouse embryonic fibroblasts for the NFI tran-
scription factor family relative to the in silico predictions
of its binding sites. The mouse genome (NCBI build 37
or mm9) was found to contain a set of 61,492 NFI pre-
dicted sites that were defined using a previously estab-
lished position weight matrix [19,28]. The predicted
sites were defined with a matrix score threshold > 85,
which corresponds to a medium in vitro binding affinity
in the range of scores that extends from a minimum of
-108 to a maximum of 100. Within this set, 2,852 pre-
dicted sites overlapped DNA sequences covering the
RefSeq annotated transcription start sites (TSS) and 5
kb of upstream sequences.
Actual in vivo binding site occupancy was estimated
using the average ChIP-Seq tag count covering each
subset of NFI predicted sites. When tag counts occur-
ring at TSS-proximal binding sites were compared to
those that do not occur near known TSS, a higher tag
counts was noted at the predicted sites, but also in
regions extending several kb away from the known
binding sites (Figure 1A). Since the DNA fragments
used in this assay did not cover a size range extending
over several kb, we reasoned that this might either result
from a surprisingly frequent association of the protein to
sequences near binding sites, or, alternatively, that it
may stem from the smaller size of the dataset compris-
ing the TSS-proximal 2,852 binding sites relative to the
non-TSS datasets of 58,640 sequences, resulting in a
relatively noisier distribution at non-bound sequences,
or from some other artefactual effects associated to the
method.
To assess the latter possibility further, we generated
control datasets of the same size as the experimental set
by randomly selecting 2,852 sequences from the 61,492
predicted sites. Comparison of distinct randomly
selected data subsets indicated comparable tag counts at
predicted binding sites, and similar signal-to-noise ratio.
Thus, the sampling method provided a reliable estima-
tion of the binding site occupancy, since several random
groups of predicted sites did not differ markedly in their
protein occupancy (Figure 1B). As before, the dataset
corresponding to TSS-proximal sites showed a more
p r o m i n e n tt a gc o u n ta r o u n dt h ep r e d i c t e ds i t e s .H o w -
ever, comparable tag counts were observed within 500
to 5000 bp windows around the predicted binding sites,
when comparing the experimental profiles to those of
control datasets of the same size. Thus, we conclude
that the group of TSS-proximal predicted sites displayed
higher protein occupancy at predicted sites when com-
pared to the randomly selected binding sites, but that it
was not the overall promoter region that was more fre-
quently bound by the protein. This suggested that
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Page 2 of 10binding sites within genomic loci upstream of core pro-
moters may bind NFI with higher apparent affinity.
NFI-bound genes show higher expression levels
Next, we assessed whether genes that bind NFI may
have some common features regarding their gene
expression levels. We selected 39,807 in vivo NFI sites
genome-wide from the ChIP-Seq data, which corre-
sponds to the genomic loci obtained from the collection
of precipitated DNA fragments. Out of this number,
3,120 in vivo sites were located within 5 kb upstream
regions of RefSeq annotated genes. As multiple in vivo
NFI sites may occur within the 5 kb upstream regions, a
total of 2881 RefSeq-annotated genes were identified to
contain one or more in vivo NFI sites. Control groups
were generated to consist of 2,881 genes randomly
selected from the total database of RefSeq genes. The
expression levels of these genes was assessed using
microarray profiling data of mRNAs obtained from mur-
ine embryo fibroblasts [29]. Again, randomly selected
groups of genes did not differ significantly in their over-
all expression levels or in their distribution profiles, with
the most prominent peak corresponding to lowly
expressed genes (Figure 2A-C). However, the transcrip-
tional levels of the group of NFI-containing genes were
distinctly higher than those of the control subgroups
(Figure 2D), with a median expression value of 6.34 for
NFI-bound genes versus 4.93, 4.97 and 4.82 for the ran-
domly selected groups of genes (two tailed t-test: p =
8.94 × 10
-61,1 . 1 5×1 0
-57,1 . 3 5×1 0
-65, respectively).
Thus, we conclude that NFI preferentially occupies pro-
moters or upstream regulatory regions of genes that
exhibit high expression levels in the cell.
NFI binding correlates with specific histone methylation
patterns
To test whether the preferential binding of NFI to
upstream regions of expressed genes may be associated
with specific chromatin modifications, we used ChIP-
Seq data for 4 different histone H3 methylations, as pre-
viously obtained from mouse embryonic fibroblasts [4].
We created average ChIP-Seq tag profiles surrounding
the TSS for each of these modifications. The group of
2,881 NFI bound genes showed higher levels of
H3K4me3 and H3K36me3, which are markers of active
promoters and transcribed regions, respectively, when
compared to the three groups of 2,881 randomly chosen
genes (Figure 3A, B). Interestingly, NFI binding at TSS
did not correlate with a modification often associated
with non-expressed or bivalent chromatin, H3K27me3,
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Figure 1 NFI family of DNA binding proteins preferentially binds upstream of initiation sites of transcription in mouse genome. A set
of 61,492 NFI predicted sites was defined in the mouse genome, NCBI build 37 or mm9. Sites were defined with a previously established
position weight matrix (sequence score threshold > 85, out of maximum 100) [28]. Within this set, 2,852 predicted sites overlapped regions 5 kb
upstream from RefSeq annotated transcriptional start sites (TSS). As a negative control for this experiment, a complementary dataset of 58,640
sites was selected (panel A) or the same number of NFI predicted sites (2,852) were randomly selected from the initial set of 61,492 predicted
sites (panel B). Four independently performed random selection are shown. Average NFI ChIP-Seq tag counts were calculated in windows of 50
bp for a region of 5 kb up- and down-stream of the selected NFI predicted sites. Tag counts were normalized globally, as a fold increase over
the genome average tag count in a window of 50 bp. Obtained data points were connected to form a continuous line.
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Page 3 of 10when compared with the profiles of the control gene
subgroups (Figure 3C), indicating that NFI binding does
not occur at promoter regions that are generally
enriched in all histone modifications. Interestingly, we
found H3K9me3, a modification recently associated with
NFI chromatin-domain boundary activity at telomeres
[ 2 6 ] ,t ob ea l s oe n r i c h e ds u r r o u n d i n gt h eT S So ft h e
group of NFI-bound genes (Figure 3D).
NFI-C most often acts as an activator of gene expression
The preferential association of NFI with expressed genes
prompted us to test whether NFI family members may
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Figure 2 Genes that contain NFI in vivo site in their 5 kb upstream regions exhibit higher expression levels. Using ChIP-Seq data, 39,807
in vivo NFI sites were defined genome-wide in mouse embryonic fibroblasts. Out of this number 3,120 in vivo sites were located within the 5 kb
upstream regions of RefSeq annotated genes. 2881 RefSeq genes were selected that contained one or more in vivo NFI sites in their 5 kb
upstream regions and the same number of genes were randomly chosen from the RefSeq gene annotation. Random selection was repeated 3
times. Histograms represent the distribution of gene expression levels for each of such defined groups. Affymetrix expression data were obtained
from the same cell type (mouse embryonic fibroblasts), from the same embryo, and using the same culturing conditions. A-C. Randomly
selected groups. D. Group of NFI occupied genes.
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Page 4 of 10have the potential to activate gene expression, or
whether their binding is rather the consequence of his-
tone modifications and chromatin accessibility at pro-
moters. For this purpose, we used gene expression
microarray data from mouse embryonic fibroblasts in
which one of the NFI factors (termed NFI-C) was
knocked out by insertional mutagenesis [30]. We
focused on differences in expression levels when com-
paring wild-type (WT) and knock-out cells (KO), and
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Figure 3 NFI binding correlates with histone H3 methylations: H3K4me3, H3K36me3, H3K9me3. 2881 NFI occupied genes in mouse
embryonic fibroblasts and 3 groups of randomly selected genes were defined as in Figure 2. ChIP-Seq data for 4 different histone H3
methylations were obtained from the same cell type (mouse embryonic fibroblasts) [4]. Average ChIP-Seq tag counts were calculated in
windows of 50 bp for a region of 5 kb up- and down-stream of the orientated transcription start sites (TSS). Tag counts were normalized
globally, as a fold increase over the genome average tag count in a window of 50 bp for the following modifications: A. H3K4me3, B.
H3K36me3, C. H3K27me3, and D. H3K9me3. Obtained data points were connected to form a continuous line. Arrows indicate the orientation of
transcription in each panel.
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Page 5 of 10decreased in the absence of NFI-C (i.e. genes potentially
directly activated by this factor). We also defined the set
of 1000 genes whose expression is most increased in the
absence of NFI-C (i.e. genes potentially directly
repressed by NFI-C). We also randomly sampled 1000
genes from all RefSeq genes as control sets. Differences
in the microarray signals of WT and KO cells (ΔE=
Ewt-Eko) were determined for each gene within defined
groups and plotted as an absolute value. The group of
genes activated by NFI-C showed the highest median
ΔE value, implicating this factor as a potent gene activa-
tor (Figure 4A). NFI-C suppressed genes also appeared
to be significantly regulated as compared to the control
groups. However, NFI-C suppressed genes displayed
moderate ΔE values, between those of the control
groups and of the group of NFI-C activated genes, indi-
cating that NFI-C is globally a less potent inhibitor of
gene expression. When considering the expression levels
in WT cells (Ewt), the group of NFI-C suppressed genes
had levels of expression that did not differ significantly
from the control subgroups (median expression value:
5.16 for down-regulated genes versus 4.81, 4.67 and 4.78
for the control gene groups, two tailed t-test: p = 0.97,
0.57, and 0.50, respectively), again indicating that NFI-C
acts as a moderate inhibitor of gene expression (Figure
4B). Overall, the group of NFI-C activated genes had
significantly higher levels of expression than the control
groups (median expression value: 6.18 for up-regulated
genes versus 4.81, 4.67 and 4.78 for random gene
groups; two tailed t-test: p = 2.04 × 10
-19,3 . 2 2×1 0
-21,
1.60 × 10
-22, respectively). These results suggest that
NFI-C member of the NFI family acts globally as an
effective gene activator.
Discussion and Conclusions
In this study, we used a random sampling procedure as
a general method to obtain reliable control datasets in
the analysis of high-throughput genomic assays. We find
that datasets of more than 100 individual values can be
used without decreasing the robustness of statistical
analysis, and that independently generated random sub-
sets of data have statistically indistinguishable global
properties. Thus, subsampling can provide a convenient
way to display and compare the noise and signals from
experimental and control datasets of the same size.
First, we showed that NFI binds preferentially those
predicted sites that are located upstream of the initiation
sites of transcription (Figure 1). Several interpretations
may be given to the preferential association of NFI to
binding sites in the proximity of TSS rather than to other
locations of the genome. It is known that NFI occupies
the promoters of many genes where it may bind synergis-
tically with some other transcription factors such as
hepatocyte nuclear factor 1 alpha, estrogen receptor, Brg-
associated factor [31-33]. Thus, the preferred occupancy
of TSS proximal sites may at least in part reflect the
synergistic association of NFI with other factors.
We also found that NFI occupy promoters or upstream
regions of the group of genes that are significantly more
expressed than the representative randomly selected con-
trol groups. Since correlation does not necessarily imply
causal relationship, this observation does not allow the
conclusion that NFI-family members actually activate the
expression of these genes. For instance, NFI might bind
highly expressed genes to suppress in part their expres-
sion, but still leaving relatively high transcription levels.
However, taken together with previous observations that
NFI activates the expression of many genes in higher
eukaryotes [20,21,32,34-37], we rather conclude that the
observed correlation may originate from a direct up-reg-
ulation of gene expression by NFI, at least for a signifi-
cant proportion of its target genes.
The hypothesis that NFI family members may directly
activate genes appears to be true for at least one of the
member of the family (i.e. NFI-C), as mRNA profiling
analysis performed on wild-type and NFI-C knock-out
cells revealed that NFI-C is a more potent gene activator
than a repressor. The 1000 genes that are most up-regu-
lated by NFI-C had significantly higher change in their
expression levels than the top 1000 down-regulated
genes. In addition, up-regulated genes showed signifi-
cantly higher expression levels than representative con-
trol gene samples selected from the total gene
population, implicating again that this factor is a potent
activator of gene expression. Since the selected in vivo
NFI binding sites are located up to 5 kb from their TSS,
which is a relatively large distance, NFI might act as
well through some of the types of remote regulation, for
instance by the establishment of a chromatin domain
boundary that would prevent the propagation of a silen-
cing chromatin structure towards the promoter [27,38].
H i s t o n eH 3m e t h y l a t i o n ss u c ha st h eH 3 K 4 m e 3a n d
H3K36me3 modifications were found to be enriched
around the TSS of NFI-occupied genes when compared
with control gene groups. This finding is consistent with
the model that NFI acts predominantly as an activator of
transcription, since H3K4me3 and H3K36me3, but not
H3K27me3, were proposed as markers of active gene tran-
scription [4,6,39]. This indicates that NFI binding to the
upstream regions may contribute to the recruitment of the
specific enzymes for the H3K4me3 and H3K36me3 modi-
fications. A genome-wide correlation of the occurrence of
H3K27me3 was also observed around TSS occurring close
to NFI-bound sites, however it was indistinguishable to
that of the control group of genes. This indicates that this
correlation results from an enrichment of H3K27me3
around at least some of the TSS, and that NFI is not
involved in the recruitment of enzymes mediating this
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Figure 4 NFI-C transcription factor acts as more potent activator of gene expression than repressor.A .D i f f e r e n c e si nt h eg e n e
expression levels in wild-type (WT) and NFI-C knock-out (KO) mouse embryonic fibroblasts were depicted for 1000 most up-regulated genes and
1000 most down-regulated genes by NFI-C, as well as for 3 independently selected random groups of 1000 genes. On the y-axis: for each gene
in such defined groups expression level in knock-out cells was subtracted from the WT expression level (Ewt-Eko) and plotted as an absolute
value. B. Affymetrix expression levels in WT cells (Ewt) for 1000 most up-regulated genes by NFI-C, 1000 most down-regulated genes by NFI-C,
and 3 sets of 1000 randomly chosen genes.
Pjanic et al. BMC Genomics 2011, 12:181
http://www.biomedcentral.com/1471-2164/12/181
Page 7 of 10modification. Thus, the enrichment of H3K27me3 modifi-
cation over the NFI bound genes represents a false positive
genome-wide correlation. Interestingly, we also found the
H3K9me3 modification to be slightly enriched in the
group of NFI bound genes. Although H3K9me3 has been
associated with a closed chromatin structure, this suggests
that NFI may be involved in the recruitment of enzymes
that mediate this modification. Interestingly, this modifica-
tion was recently associated with a chromatin domain
boundary effect at telomeric regions in human cells [26].
In this study, NFI was shown to prevent the propagation
of a silencing chromatin structure from the telomere, and
the expressed genes protected from telomeric silencing by
NFI were shown to have elevated H3K9me3 marks at spe-
cific telomeric positions. Thus, we may conclude from
these studies that the enrichment in H3K9me3 may be a
hallmark of gene expression activation by NFI.
Methods
Cell culture
Mouse embryonic fibroblasts (MEF) were extracted from
mouse embryos of 14.5 days. Cells from WT (wild-type)
and NFI-C knock-out embryos were cultured under the
following conditions: 37°C, 5% CO2,D M E M( G I B C O ,
41966), Supplementary 10% FBS (GIBCO, Fetal Bovine
Serum, qualified origin US, 26140-079), 1% v/v nones-
sential amino-acids (GIBCO, 11140-035), 1% v/v L-glu-
tamine (GIBCO, 25030-024).
Chromatin Immuno-precipitation (ChIP)
Chromatin was extracted from approximately 20,000,000
primary mouse embryonic fibroblasts grown in culture and
cross-linked using 11% formaldehyde. Extracted chromatin
was fragmented to the average fragment size of 1000 bp
using high-frequency sound sonication on VibraCell-75455
(Bioblock Scientific). ChIP was performed as described
before [27] using the commercial antibody against NFI
group of proteins (NFI (H300): sc-5567, SantaCruz Biotech-
nology). Antibody complexes were precipitated using rPro-
tein A Sepharose Fast Flow (Amersham Biosciences).
Illumina/Solexa sequencing
ChIP DNA was processed using the contents of the
ChIP-Seq Sample Prep Kit (Illumina). Size range of tem-
plates was selected by loading the entire processed sam-
ple on a 2% agarose gel and excising the gel region of
50-400 bp. PCR amplification of the gel-extracted DNA
was performed for 18 cycles using the adapter-specific
primers. Each sample was loaded into 3 separate flow
cell channels of the Illumina Cluster Station and then
subjected to sequencing-by-synthesis on the Illumina
Genome Analyzer sequencing system. For each of the
samples, sequence reads from independent channels
were pooled together.
Data analyses
Clustering and correlation analyses of mapped reads
were performed using ChIP-peak and ChIP-cor tools
available on the ChIP-Seq Analysis Server [40,41]. In
vivo NFI sites were defined using the ChIP-peak tool
and applying the following parameters: window width -
300 bp, vicinity range - 300 bp, peak threshold - 5 tags,
count cut-off - 1 tag, repeat filtering-on. Correlation
analyses were made using ChIP-cor tool and applying
the following parameters: window width - 50 bp, count
cut-off - 1, normalization - global. Galaxy tools were
used to operate on the genomic intervals [42,43].
Random sampling algorithm
Random sampling algorithm was written in C++ lan-
guage and compiled in Microsoft Visual Studio as
detailed in the Additional file 1 online. The algorithm
uses the computer system date and time as a constantly
increasing number for seeding the random number gen-
erators at each independent run of the random number
generator. Each random number so generated was used
to select a single entry line from the dataset to be sub-
sampled, with the limitation that a single line of the
input file could be selected only once. The source code
for random sampling algorithm is available in the addi-
tional materials online (Additional file 1).
Datasets repository
ChIP-Seq data for the wild type and NFI-C knock-out
mouse embryonic fibroblasts were deposited at the
Gene Expression Omnibus (GEO) repository under the
accession number GSE15844. Gene expression microar-
r a yd a t af o rt h ew i l dt y p ea n dN F I - Ck n o c k - o u tm o u s e
embryonic fibroblasts were taken from the GEO reposi-
tory under the accession number GSE15871. ChIP-Seq
data for histone methylations in mouse embryonic fibro-
blasts (H3K4me3, H3K9me3, H3K27me3, H3K36me3)
were taken from GEO repository under the accession
number GSE12241.
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List of Abbreviations
NFI: Nuclear Factor I; NFI-C: Nuclear Factor I - C; CTF: CAAT box transcription
factors; ChIP: Chromatin immuno-precipitation; ChIP-Seq: Chromatin
immuno-precipitation sequencing; MEFs: Mouse embryonic fibroblasts; TSS:
Transcriptional start site; TFs: Transcription factors; NFI-C KO: Nuclear Factor I
- C knock out; WT: Wild type
Pjanic et al. BMC Genomics 2011, 12:181
http://www.biomedcentral.com/1471-2164/12/181
Page 8 of 10Acknowledgements
We would like to acknowledge Fasteris, SA, CH-1228 Plan-les-Ouates,
Switzerland for providing fast and accurate service of Illumina Genome
Analyzer high-throughput DNA sequencing and for processing the data
output of obtained sequence tags through ELAND mapping software
pipeline. This work was supported by the grants from the University of
Lausanne, Switzerland.
Author details
1Institute of Biotechnology, University of Lausanne, and Center for
Biotechnology of the University of Lausanne and École Polytechnique
Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
2Software
Examination and Certification Laboratory, Faculty of Mathematics, University
of Belgrade, 11000 Belgrade, Serbia.
3Swiss Institute for Experimental Cancer
Research, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne,
Switzerland.
4Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O.
Box, CH-4002 Basel, Switzerland.
5Universität Basel, Petersplatz 1, CH-4003
Basel, Switzerland.
6Swiss Institute of Bioinformatics, EPFL SV ISREC, AAB 0 09
(Bâtiment AAB), Station 15, CH-1015 Lausanne, Switzerland.
7Department of
Mathematics, University of Fribourg, CH-1700 Fribourg, Switzerland.
Authors’ contributions
MP conceived the study, carried out the ChIP-Seq experiments, participated
in the data analysis and drafted the manuscript. PP developed the random
sampling algorithm and participated in the data analysis. CS, GA and PB
developed ChIP-Seq analysis tools and participated in the data analysis. AG,
GP made substantial contributions to the data collection and interpretation
of data. CM, PB and NM participated in the design of the study, made
substantial contributions to the interpretation of data, provided essential
data revisions, and helped to draft the manuscript. All authors have read
and approved the final manuscript.
Received: 15 August 2009 Accepted: 7 April 2011
Published: 7 April 2011
References
1. Planet PJ, DeSalle R, Siddall M, Bael T, Sarkar IN, Stanley SE: Systematic
analysis of DNA microarray data: ordering and interpreting patterns of
gene expression. Genome Res 2001, 11(7): 1149-1155.
2. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P: Coexpression analysis of human
genes across many microarray data sets. Genome Res 2004, 14(6):
1085-1094.
3. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T,
Euskirchen G, Bernier B, Varhol R, Delaney A, et al: Genome-wide
profiles of STAT1 DNA association using chromatin
immunoprecipitation and massively parallel sequencing. Nat
Methods 2007, 4(8): 651-657.
4. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P,
Brockman W, Kim TK, Koche RP, et al: Genome-wide maps of chromatin
state in pluripotent and lineage-committed cells. Nature 2007, 448(7153):
553-560.
5. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S,
Guenther MG, Johnston WK, Wernig M, Newman J, et al: Connecting
microRNA genes to the core transcriptional regulatory circuitry of
embryonic stem cells. Cell 2008, 134(3): 521-533.
6. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G,
Chepelev I, Zhao K: High-resolution profiling of histone methylations in
the human genome. Cell 2007, 129(4): 823-837.
7. Yang MQ, Athey BD, Arabnia HR, Sung AH, Liu Q, Yang JY, Mao J, Deng Y:
High-throughput next-generation sequencing technologies foster new
cutting-edge computing techniques in bioinformatics. BMC genomics
2009, 10(Suppl 1): I1.
8. Lefrancois P, Euskirchen GM, Auerbach RK, Rozowsky J, Gibson T,
Yellman CM, Gerstein M, Snyder M: Efficient yeast ChIP-Seq using
multiplex short-read DNA sequencing. BMC genomics 2009, 10: 37.
9. Taylor J, Schenck I, Blankenberg D, Nekrutenko A: Using galaxy to perform
large-scale interactive data analyses. In Current protocols in bioinformatics/
editoral board Edited by: Andreas D Baxevanis, et al 2007, Chapter 10(Unit
10): 15.
10. Albert I, Wachi S, Jiang C, Pugh BF: GeneTrack–a genomic data processing
and visualization framework. Bioinformatics 2008, 24(10): 1305-1306.
11. Ji H, Jiang H, Ma W, Johnson DS, Myers RM, Wong WH: An integrated
software system for analyzing ChIP-chip and ChIP-seq data. Nat
Biotechnol 2008, 26(11): 1293-1300.
12. Rozowsky J, Euskirchen G, Auerbach RK, Zhang ZD, Gibson T, Bjornson R,
Carriero N, Snyder M, Gerstein MB: PeakSeq enables systematic scoring of
ChIP-seq experiments relative to controls. Nat Biotechnol 2009, 27(1):
66-75.
13. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE,
Nussbaum C, Myers RM, Brown M, Li W, et al: Model-based analysis of
ChIP-Seq (MACS). Genome Biol 2008, 9(9): R137.
14. Gamage J, Weerahandi S: Size performance of some tests in one-way
anova. Communications in Statistics - Simulation and Computation 1998,
27(3): 625-640.
15. Wittkowski KM: Statistical analysis of unbalanced and incomplete designs
- experiences with BMDP and SAS. Statistical software newsletter 1991.
16. Qian F, Kruse U, Lichter P, Sippel AE: Chromosomal localization of the four
genes (NFIA, B, C, and X) for the human transcription factor nuclear
factor I by FISH. Genomics 1995, 28(1): 66-73.
17. Gronostajski RM: Roles of the NFI/CTF gene family in transcription and
development. Gene 2000, 249(1-2): 31-45.
18. Santoro C, Mermod N, Andrews PC, Tjian R: A family of human CCAAT-
box-binding proteins active in transcription and DNA replication:
cloning and expression of multiple cDNAs. Nature 1988, 334(6179):
218-224.
19. Roulet E, Bucher P, Schneider R, Wingender E, Dusserre Y, Werner T,
Mermod N: Experimental analysis and computer prediction of CTF/NFI
transcription factor DNA binding sites. J Mol Biol 2000, 297(4): 833-848.
20. Furlong EE, Rein T, Martin F: YY1 and NF1 both activate the human p53
promoter by alternatively binding to a composite element, and YY1 and
E1A cooperate to amplify p53 promoter activity. Mol Cell Biol 1996,
16(10): 5933-5945.
21. Johansson EM, Kannius-Janson M, Bjursell G, Nilsson J: The p53 tumor
suppressor gene is regulated in vivo by nuclear factor 1-C2 in the
mouse mammary gland during pregnancy. Oncogene 2003, 22(38):
6061-6070.
22. Wickenheisser JK, Nelson-DeGrave VL, Quinn PG, McAllister JM: Increased
cytochrome P450 17alpha-hydroxylase promoter function in theca cells
isolated from patients with polycystic ovary syndrome involves nuclear
factor-1. Mol Endocrinol 2004, 18(3): 588-605.
23. Ouellet S, Vigneault F, Lessard M, Leclerc S, Drouin R, Guerin SL:
Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A
(p21) gene by NFI in proliferating human cells. Nucleic Acids Res 2006,
34(22): 6472-6487.
24. Gao S, Zhao Y, Kong L, Toselli P, Chou IN, Stone P, Li W: Cloning and
characterization of the rat lysyl oxidase gene promoter: identification of
core promoter elements and functional nuclear factor I-binding sites. J
Biol Chem 2007, 282(35): 25322-25337.
25. O’Donnell A, Yang SH, Sharrocks AD: MAP kinase-mediated c-fos
regulation relies on a histone acetylation relay switch. Mol Cell 2008,
29(6): 780-785.
26. Esnault G, Majocchi S, Martinet D, Besuchet-Schmutz N, Beckmann JS,
Mermod N: Transcription factor CTF1 acts as a chromatin domain
boundary that shields human telomeric genes from silencing. Mol Cell
Biol 2009, 29(9): 2409-2418.
27. Ferrari S, Simmen KC, Dusserre Y, Muller K, Fourel G, Gilson E, Mermod N:
Chromatin domain boundaries delimited by a histone-binding protein in
yeast. J Biol Chem 2004, 279(53): 55520-55530.
28. Roulet E, Busso S, Camargo AA, Simpson AJ, Mermod N, Bucher P: High-
throughput SELEX SAGE method for quantitative modeling of
transcription-factor binding sites. Nat Biotechnol 2002, 20(8): 831-835.
29. Plasari G, Calabrese A, Dusserre Y, Gronostajski RM, McNair A, Michalik L,
Mermod N: Nuclear factor I-C links platelet-derived growth factor and
transforming growth factor beta1 signaling to skin wound healing
progression. Mol Cell Biol 2009, 29(22): 6006-6017.
30. Steele-Perkins G, Butz KG, Lyons GE, Zeichner-David M, Kim HJ, Cho MI,
Gronostajski RM: Essential role for NFI-C/CTF transcription-replication
factor in tooth root development. Mol Cell Biol 2003, 23(3): 1075-1084.
31. Hebbar PB, Archer TK: Chromatin-dependent cooperativity between site-
specific transcription factors in vivo. J Biol Chem 2007, 282(11): 8284-8291.
32. Satoh S, Noaki T, Ishigure T, Osada S, Imagawa M, Miura N, Yamada K,
Noguchi T: Nuclear factor 1 family members interact with hepatocyte
Pjanic et al. BMC Genomics 2011, 12:181
http://www.biomedcentral.com/1471-2164/12/181
Page 9 of 10nuclear factor 1alpha to synergistically activate L-type pyruvate kinase
gene transcription. J Biol Chem 2005, 280(48): 39827-39834.
33. Zhao LH, Ba XQ, Wang XG, Zhu XJ, Wang L, Zeng XL: BAF complex is
closely related to and interacts with NF1/CTF and RNA polymerase II in
gene transcriptional activation. Acta Biochim Biophys Sin (Shanghai) 2005,
37(7): 440-446.
34. Hebbar PB, Archer TK: Nuclear factor 1 is required for both hormone-
dependent chromatin remodeling and transcriptional activation of the
mouse mammary tumor virus promoter. Mol Cell Biol 2003, 23(3): 887-898.
35. Kannius-Janson M, Johansson EM, Bjursell G, Nilsson J: Nuclear factor 1-C2
contributes to the tissue-specific activation of a milk protein gene in the
differentiating mammary gland. J Biol Chem 2002, 277(20): 17589-17596.
36. Ling G, Hauer CR, Gronostajski RM, Pentecost BT, Ding X: Transcriptional
regulation of rat CYP2A3 by nuclear factor 1: identification of a novel
NFI-A isoform, and evidence for tissue-selective interaction of NFI with
the CYP2A3 promoter in vivo. J Biol Chem 2004, 279(27): 27888-27895.
37. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B: A
nuclear factor 1 binding site mediates the transcriptional activation of a
type I collagen promoter by transforming growth factor-beta. Cell 1988,
52(3): 405-414.
38. Fourel G, Boscheron C, Revardel E, Lebrun E, Hu YF, Simmen KC, Muller K,
Li R, Mermod N, Gilson E: An activation-independent role of transcription
factors in insulator function. EMBO Rep 2001, 2(2): 124-132.
39. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P,
Bernstein BE, Jaenisch R, Lander ES, Meissner A: Dissecting direct
reprogramming through integrative genomic analysis. Nature 2008,
454(7200): 49-55.
40. ChIP-Seq Analysis Server. [http://ccg.vital-it.ch/chipseq/].
41. ChIP-Seq Analysis tools - download repository. [https://sourceforge.net/
projects/chip-seq/].
42. Galaxy tools. [http://main.g2.bx.psu.edu/].
43. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y,
Blankenberg D, Albert I, Taylor J, et al: Galaxy: a platform for interactive
large-scale genome analysis. Genome Res 2005, 15(10): 1451-1455.
doi:10.1186/1471-2164-12-181
Cite this article as: Pjanic et al.: Nuclear factor I revealed as family of
promoter binding transcription activators. BMC Genomics 2011 12:181.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Pjanic et al. BMC Genomics 2011, 12:181
http://www.biomedcentral.com/1471-2164/12/181
Page 10 of 10